Report cover image

Global Rifapentine Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 99 Pages
SKU # APRC20549319

Description

Summary

According to APO Research, The global Rifapentine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Rifapentine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Rifapentine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Rifapentine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Rifapentine include Changzheng Pharma, Sine Pharma, Sanofi, MED-SHINE and Foutune Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rifapentine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rifapentine.
The Rifapentine market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rifapentine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Rifapentine Segment by Company

Changzheng Pharma
Sine Pharma
Sanofi
MED-SHINE
Foutune Pharma
Rifapentine Segment by Type

20 Capsules/Box
24 Capsules/Box
Rifapentine Segment by Application

Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Rifapentine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rifapentine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rifapentine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rifapentine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Rifapentine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Rifapentine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

99 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Rifapentine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Rifapentine Sales Estimates and Forecasts (2020-2031)
1.3 Rifapentine Market by Type
1.3.1 20 Capsules/Box
1.3.2 24 Capsules/Box
1.4 Global Rifapentine Market Size by Type
1.4.1 Global Rifapentine Market Size Overview by Type (2020-2031)
1.4.2 Global Rifapentine Historic Market Size Review by Type (2020-2025)
1.4.3 Global Rifapentine Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Rifapentine Sales Breakdown by Type (2020-2025)
1.5.2 Europe Rifapentine Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Rifapentine Sales Breakdown by Type (2020-2025)
1.5.4 South America Rifapentine Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Rifapentine Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Rifapentine Industry Trends
2.2 Rifapentine Industry Drivers
2.3 Rifapentine Industry Opportunities and Challenges
2.4 Rifapentine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Rifapentine Revenue (2020-2025)
3.2 Global Top Players by Rifapentine Sales (2020-2025)
3.3 Global Top Players by Rifapentine Price (2020-2025)
3.4 Global Rifapentine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Rifapentine Major Company Production Sites & Headquarters
3.6 Global Rifapentine Company, Product Type & Application
3.7 Global Rifapentine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Rifapentine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Rifapentine Players Market Share by Revenue in 2024
3.8.3 2023 Rifapentine Tier 1, Tier 2, and Tier 3
4 Rifapentine Regional Status and Outlook
4.1 Global Rifapentine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Rifapentine Historic Market Size by Region
4.2.1 Global Rifapentine Sales in Volume by Region (2020-2025)
4.2.2 Global Rifapentine Sales in Value by Region (2020-2025)
4.2.3 Global Rifapentine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Rifapentine Forecasted Market Size by Region
4.3.1 Global Rifapentine Sales in Volume by Region (2026-2031)
4.3.2 Global Rifapentine Sales in Value by Region (2026-2031)
4.3.3 Global Rifapentine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Rifapentine by Application
5.1 Rifapentine Market by Application
5.1.1 Retail Pharmacies
5.1.2 Online Pharmacies
5.1.3 Hospital Pharmacies
5.2 Global Rifapentine Market Size by Application
5.2.1 Global Rifapentine Market Size Overview by Application (2020-2031)
5.2.2 Global Rifapentine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Rifapentine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Rifapentine Sales Breakdown by Application (2020-2025)
5.3.2 Europe Rifapentine Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Rifapentine Sales Breakdown by Application (2020-2025)
5.3.4 South America Rifapentine Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Rifapentine Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Changzheng Pharma
6.1.1 Changzheng Pharma Comapny Information
6.1.2 Changzheng Pharma Business Overview
6.1.3 Changzheng Pharma Rifapentine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Changzheng Pharma Rifapentine Product Portfolio
6.1.5 Changzheng Pharma Recent Developments
6.2 Sine Pharma
6.2.1 Sine Pharma Comapny Information
6.2.2 Sine Pharma Business Overview
6.2.3 Sine Pharma Rifapentine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sine Pharma Rifapentine Product Portfolio
6.2.5 Sine Pharma Recent Developments
6.3 Sanofi
6.3.1 Sanofi Comapny Information
6.3.2 Sanofi Business Overview
6.3.3 Sanofi Rifapentine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Rifapentine Product Portfolio
6.3.5 Sanofi Recent Developments
6.4 MED-SHINE
6.4.1 MED-SHINE Comapny Information
6.4.2 MED-SHINE Business Overview
6.4.3 MED-SHINE Rifapentine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MED-SHINE Rifapentine Product Portfolio
6.4.5 MED-SHINE Recent Developments
6.5 Foutune Pharma
6.5.1 Foutune Pharma Comapny Information
6.5.2 Foutune Pharma Business Overview
6.5.3 Foutune Pharma Rifapentine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Foutune Pharma Rifapentine Product Portfolio
6.5.5 Foutune Pharma Recent Developments
7 North America by Country
7.1 North America Rifapentine Sales by Country
7.1.1 North America Rifapentine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Rifapentine Sales by Country (2020-2025)
7.1.3 North America Rifapentine Sales Forecast by Country (2026-2031)
7.2 North America Rifapentine Market Size by Country
7.2.1 North America Rifapentine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Rifapentine Market Size by Country (2020-2025)
7.2.3 North America Rifapentine Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Rifapentine Sales by Country
8.1.1 Europe Rifapentine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Rifapentine Sales by Country (2020-2025)
8.1.3 Europe Rifapentine Sales Forecast by Country (2026-2031)
8.2 Europe Rifapentine Market Size by Country
8.2.1 Europe Rifapentine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Rifapentine Market Size by Country (2020-2025)
8.2.3 Europe Rifapentine Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Rifapentine Sales by Country
9.1.1 Asia-Pacific Rifapentine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Rifapentine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Rifapentine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Rifapentine Market Size by Country
9.2.1 Asia-Pacific Rifapentine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Rifapentine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Rifapentine Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Rifapentine Sales by Country
10.1.1 South America Rifapentine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Rifapentine Sales by Country (2020-2025)
10.1.3 South America Rifapentine Sales Forecast by Country (2026-2031)
10.2 South America Rifapentine Market Size by Country
10.2.1 South America Rifapentine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Rifapentine Market Size by Country (2020-2025)
10.2.3 South America Rifapentine Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Rifapentine Sales by Country
11.1.1 Middle East and Africa Rifapentine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Rifapentine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Rifapentine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Rifapentine Market Size by Country
11.2.1 Middle East and Africa Rifapentine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Rifapentine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Rifapentine Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Rifapentine Value Chain Analysis
12.1.1 Rifapentine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Rifapentine Production Mode & Process
12.2 Rifapentine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Rifapentine Distributors
12.2.3 Rifapentine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.